The univariate analysis of molecular and clinicopathological variables identified tumor location (p = 0.201), sidedness (p < 0.001), TNM stage (p = 0.076), MMR status (p = 0.157), MRE11A status (p = 0.121), and PALB2 status (p = 0.259) as candidates to independently predict the risk of death in CRC patients (Table 4). The gene discussed is PALB2; the disease is neoplasm.